#United States #Eden Prairie #SynerFuse™ #Velentium Medical #spinal fusion

SynerFuse™ and Velentium Medical Join Forces to Revolutionize Spine Surgery

In a significant advancement in the field of spinal surgery, SynerFuse™ and Velentium Medical have announced an innovative partnership aimed at scaling the deeply integrated spinal fusion and direct nerve stimulation procedures. This news follows the successful completion of a clinical proof-of-concept study, marking an important milestone in their commitment to enhancing patient care and outcomes.

A New Era for Spinal Procedures

The SynerFuse™ e-TLIF™ procedure stands at the forefront of this partnership, aiming to provide a novel alternative for the more than 500,000 patients who undergo traditional spinal fusion surgery in the United States every year. The collaboration aims to integrate neuromodulation into spinal decompression and fusion, providing a comprehensive approach to managing spinal instability and pain.

As Zenanko, a spokesperson for SynerFuse™, remarked, “With the completion of our proof-of-concept study, we advanced our mission to improve patient quality of life.” This study demonstrated both the safety and feasibility of blending direct nerve stimulation with conventional surgical methods, paving the way for a new treatment narrative in spinal health.

Insights from Clinical Studies

The clinical trial, which involved insights from 15 patients, has informed the design of an implantable device that was developed specifically for addressing neuropathic and mechanical pain. According to Dr. Rohan Lall, the Chief Medical Officer of SynerFuse™, this device is a product of meticulous design from surgeons for surgeons, enhancing procedural effectiveness.

“Requiring only a single incision and involving direct visual placement of the neurostimulation device will make the SynerFuse™ e-TLIF™ procedure safer for patients,” said Dr. Michael C. Park, the principal investigator at the University of Minnesota, underscoring the procedure's potential to redefine post-operative care.

Cutting-Edge Development and Manufacturing

Velentium Medical, based in Richmond, Texas, brings a wealth of experience in medical device design and manufacturing to the table, which is pivotal in scaling production for the new SynerFuse™ device. Their Chairman, Dan Purvis, expressed enthusiasm about the integration of advanced neuromodulation therapies in spinal surgeries.

Tim Carroll, a co-founder of Velentium Medical, stated, “We are pleased to have been selected by SynerFuse™ as their development and manufacturing partner.” This partnership not only exemplifies their capability but also their commitment to transforming patients' lives through innovative medical solutions.

Addressing Chronic Lower Back Pain

Chronic lower back pain (cLBP) significantly affects millions of individuals across the globe. Though conventional spinal fusion surgeries are a common solution, many patients experience residual pain post-operation, with studies indicating that nearly 40% of spinal fusion patients suffer from Failed Back Surgery Syndrome (FBSS).

SynerFuse™ stands to change this narrative by providing a dual approach to pain management. Their patented therapy seamlessly blends spinal fusion with neuromodulation capabilities, offering a significant alternative to painful opioids often prescribed for managing chronic pain.

“Unlocking an additional safe modality to treat surgical, neuropathic, and mechanical back and leg pain while reducing patients' exposure to opioids is crucial,” said Dr. Deepak Reddy, another principal investigator for the study. This multifaceted approach aims to improve the quality of life for those affected by chronic conditions related to lower back pain.

Conclusion: Looking Ahead

As SynerFuse™ and Velentium Medical continue to develop this pioneering approach to spinal fusion and neuromodulation, the medical community and patients alike await the arrival of this groundbreaking solution. With their shared dedication towards enhancing patient-centric care, this partnership not only signifies a leap forward in surgical technology but also offers hope for a better quality of life for countless individuals struggling with chronic back pain. For more information on SynerFuse™, visit their website at www.synerfuse.com or check out Velentium Medical's innovations at www.velentiummedical.com.